Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $3.25 $4.50 Thursday, 9th May 2024 AVXL stock ended at $3.88. This is 4.58% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 9.32% from a day low at $3.60 to a day high of $3.93.
90 days $3.25 $6.15
52 weeks $3.25 $10.31

Historical Anavex Life Sciences Corp. prices

Date Open High Low Close Volume
Jul 06, 2016 $6.26 $6.40 $6.03 $6.30 643 600
Jul 05, 2016 $5.80 $6.47 $5.66 $6.26 1 041 900
Jul 01, 2016 $6.17 $6.17 $5.60 $5.89 1 225 300
Jun 30, 2016 $5.61 $6.11 $5.39 $6.11 2 151 000
Jun 29, 2016 $5.22 $5.25 $4.84 $5.25 858 100
Jun 28, 2016 $4.76 $4.81 $4.60 $4.78 428 200
Jun 27, 2016 $4.60 $4.66 $4.37 $4.54 551 900
Jun 24, 2016 $4.08 $4.63 $4.06 $4.55 3 614 900
Jun 23, 2016 $4.15 $4.39 $4.13 $4.27 524 800
Jun 22, 2016 $4.30 $4.32 $4.07 $4.15 457 400
Jun 21, 2016 $4.32 $4.32 $4.01 $4.23 362 400
Jun 20, 2016 $4.06 $4.18 $4.03 $4.11 272 100
Jun 17, 2016 $4.28 $4.28 $4.02 $4.02 272 400
Jun 16, 2016 $4.16 $4.30 $4.05 $4.29 344 115
Jun 15, 2016 $4.09 $4.16 $4.01 $4.15 170 280
Jun 14, 2016 $4.05 $4.14 $3.95 $4.08 291 210
Jun 13, 2016 $4.20 $4.33 $4.01 $4.05 556 493
Jun 10, 2016 $4.44 $4.44 $4.17 $4.21 343 485
Jun 09, 2016 $4.42 $4.54 $4.34 $4.44 275 496
Jun 08, 2016 $4.69 $4.73 $4.30 $4.35 449 818
Jun 07, 2016 $4.74 $4.84 $4.61 $4.64 290 404
Jun 06, 2016 $4.62 $4.75 $4.46 $4.70 435 389
Jun 03, 2016 $4.70 $4.70 $4.45 $4.55 453 205
Jun 02, 2016 $4.38 $4.70 $4.30 $4.63 479 265
Jun 01, 2016 $4.46 $4.46 $4.35 $4.39 289 124
Click to get the best stock tips daily for free!

About Anavex Life Sciences Corp.

Anavex Life Sciences . Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT